B of A Securities Maintains Buy on Guardant Health, Raises Price Target to $190

Guardant Health

Guardant Health

GH

0.00

B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ: GH) with a Buy and raises the price target from $135 to $190.